Inclusion completed

Immunochemotherapy in Primary Central Nervous System Lymphoma with Rituximab, HD-MTX, HD-Ara C, cyclophosphamide, ifosfamide, vincristine,vindesine, temozolomi-de and DepoCyte induction followed by maintenance treatment in elderly patients with temozolomi

Cancer type: Lymphoma

Phase: II

Principal Investigator: Leppä Sirpa

Country: FI

Keywords: Finland

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01458730?term=NCT01458730&rank=1